March 2011 - Volume 29 - Issue 3 : Journal of Hypertension

Journal Logo

March 2011 - Volume 29 - Issue 3
pp: 409-622


Blood pressure measurement

Genetic aspects

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

Brugts, Jasper J; Isaacs, Aaron; de Maat, Moniek PM; More

Journal of Hypertension. 29(3):509-519, March 2011.

Pathophysiological aspects

Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli

Galán, María; Miguel, Marta; Beltrán, Amada E; More

Journal of Hypertension. 29(3):529-536, March 2011.

Sympathetic activity


Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin

Cheng, Xian Wu; Kuzuya, Masafumi; Sasaki, Takeshi; More

Journal of Hypertension. 29(3):542-552, March 2011.


Therapeutic aspects